Home | About CHA | Contacts| News | Quick Links | Search

 
         

 

For Patients For Providers Academics Careers Services Locations How to Give  

 

About Us

News Home

Press Releases

Research

Experts

Awards

Archives

Join Our Media mailing list

Media Opportunity Consent Form (doc)

 
 
 

 

NEWS FROM CAMBRIDGE HEALTH ALLIANCE

December 18, 2009

Cambridge Health Alliance Offers Innovative Treatment for Opioid Addiction

Cambridge, MA…Are you concerned about your opioid drug use, or that of a loved one? The holiday season is often a time of strain and stress, especially for individuals who are struggling with addiction. Yet, the advent of a new year is a time when many people make efforts toward change. The Opioid Addiction and Family Project may be able to help.

The Opioid Addiction and Family Project is designed to provide high-quality, no-cost treatment for adults addicted to opioids, which are chemical substances commonly used for pain relief, such as heroin or oxycodone. The program is a study conducted by researchers at Cambridge Health Alliance (CHA) and Harvard Medical School to examine if adding family counseling to individual counseling and recovery medication improves treatment outcomes.

"Over the past two years, we have seen some tremendous success stories: young people who have stopped out-of-control drug use and gotten their lives back on track," said Mark Albanese, MD, CHA's Director of Addiction Services. "Our communities are plagued by opioid abuse - we are fortunate that NIDA (National Institute on Drug Abuse) has offered valuable support for this program."

Adults seeking help for an opioid addiction may be eligible for the program if they are between 21 and 65 years old and live with a family member (spouse, intimate partner, parent, or other family member). All participants receive free individual counseling, and half of all participants also receive free family counseling. The counseling consists of 32 sessions over 4-5 months.

Additionally, all participants receive free Naltrexone medication. Naltrexone is an opiate blocker approved by the Food and Drug Administration for the treatment of opioid dependence that has been shown to improve treatment outcomes. Counseling sessions take place at CHA's Central Street Health Center in Somerville, Mass.

For more information, please visit www.cha.harvard.edu/opioid or call the Opioid Addiction and Family Project at Cambridge Health Alliance at (617) 591-6055.

Cambridge Health Alliance is an innovative, award-winning health system that provides high quality care in Cambridge, Somerville, and Boston's metro-north communities. It includes three hospital campuses, a network of primary care and specialty practices, the Cambridge Public Health Dept., and the Network Health plan. CHA is a Harvard Medical School teaching affiliate and is also affiliated with Harvard School of Public Health, Harvard School of Dental Medicine, and Tufts University School of Medicine. Visit us online at www.challiance.org.

 


 

 

Media Contacts

David Cecere
Cambridge Health Alliance
Phone: 617-503-8428
dcecere@challiance.org

Learn more!

CHA Opioid Addiction and Family Project